Literature DB >> 15753899

Resident CD8+ T cells suppress CD4+ T cell-dependent late allergic airway responses.

Susumu Isogai1, Sean Jedrzkiewicz, Rame Taha, Qutayba Hamid, James G Martin.   

Abstract

BACKGROUND: The role of CD8+ T cells in the immune response to airway challenge with an allergen is poorly understood.
OBJECTIVE: The aim of this study was to test the hypothesis that resident naive CD8+ T cells modulate the magnitude of CD4+ T cell-dependent allergic airway responses.
METHODS: Cervical lymph node CD4+ T cells (2 x 10(6)) were harvested from ovalbumin (OVA)- or sham-sensitized rats and injected intraperitoneally into naive Brown Norway recipients. The recipients were treated with a CD8alpha mAb (OX-8) to deplete the resident CD8+ T cells (n = 12) or mouse ascites (n = 12). Two days after adoptive transfer, the recipient animals were OVA challenged, lung resistance was measured for 8 hours, and bronchoalveolar lavage (BAL) was performed.
RESULTS: After OVA challenge, primed CD4-transferred CD8-depleted rats had larger early airway responses and late airway responses compared with primed CD4-transferred CD8-nondepleted rats (early airway responses: 158.6% +/- 19.2% vs 115.7% +/- 5.9%, P < .05; late airway responses: 8.5% +/- 1.7% vs 4.4% +/- 0.9%, P < .05). BAL eosinophilia was also greater (4.67% +/- 0.45% vs 2.34 +/- 0.26%, P < .01). The cells in BAL fluid expressing IL-4 mRNA were not significantly changed by CD8 depletion, but IL-5 mRNA+ cells were higher in number, and IFN-gamma mRNA+ cells were fewer in the CD8-depleted group.
CONCLUSIONS: Resident CD8+ T cells downregulate the late allergic response and airway inflammation evoked by CD4+ T-cell transfers in Brown Norway rats. This downregulation does not require antigen priming.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753899     DOI: 10.1016/j.jaci.2004.11.036

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.

Authors:  Sarah E Weber; Haijun Tian; Liise-anne Pirofski
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

Review 2.  Functions of T cells in asthma: more than just T(H)2 cells.

Authors:  Clare M Lloyd; Edith M Hessel
Journal:  Nat Rev Immunol       Date:  2010-11-09       Impact factor: 53.106

3.  Suppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccine.

Authors:  J W Wells; K Choy; C M Lloyd; A Noble
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

4.  Depletion of CD8+ T cells enhances airway remodelling in a rodent model of asthma.

Authors:  Kimitake Tsuchiya; Susumu Isogai; Meiyo Tamaoka; Naohiko Inase; Takumi Akashi; James G Martin; Yasuyuki Yoshizawa
Journal:  Immunology       Date:  2008-06-17       Impact factor: 7.397

5.  Pulmonary dendritic cells and alveolar macrophages are regulated by gammadelta T cells during the resolution of S. pneumoniae-induced inflammation.

Authors:  A C Kirby; D J Newton; S R Carding; P M Kaye
Journal:  J Pathol       Date:  2007-05       Impact factor: 7.996

6.  Characterisation of a murine model of the late asthmatic response.

Authors:  Katie Baker; Kristof Raemdonck; Robert J Snelgrove; Maria G Belvisi; Mark A Birrell
Journal:  Respir Res       Date:  2017-04-11

7.  CD4⁺ and CD8⁺ T cells play a central role in a HDM driven model of allergic asthma.

Authors:  Kristof Raemdonck; Katie Baker; Nicole Dale; Eric Dubuis; Fisnik Shala; Maria G Belvisi; Mark A Birrell
Journal:  Respir Res       Date:  2016-04-25

Review 8.  Elucidating novel disease mechanisms in severe asthma.

Authors:  Richard Y Kim; Brittany Rae; Rachel Neal; Chantal Donovan; James Pinkerton; Lohis Balachandran; Malcolm R Starkey; Darryl A Knight; Jay C Horvat; Philip M Hansbro
Journal:  Clin Transl Immunology       Date:  2016-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.